aetherAI
aetherAI is a Taipei-based medical-imaging AI company that builds computer-vision software for digital pathology and endoscopy, with deployments in 23+ hospitals across Taiwan, the US, Germany, Japan, and Vietnam, and biopharma engagements with Novartis, ACT Genom, and Ono Pharmaceutical.
- Company typePublic
- Founded2015
- HeadquartersTaipei, Taiwan
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What aetherAI does
aetherAI is a Taipei-headquartered medical-imaging AI company founded in October 2015 that builds computer-vision software for digital pathology and endoscopy, with deployments in more than 23 hospitals across Taiwan, the United States, Germany, Japan, and (as of 2025) Vietnam. Its flagship aetherSlide platform integrates a whole-slide image viewer and case management with AI inference for pathology workflows, complemented by aetherAI Endo for colon polyp detection, aetherAI Hema for bone-marrow analysis, and an AI-assisted lymph-node assessment module. The underlying engine is the proprietary True GigaPixel AI architecture, covered by two US patents and validated in a Nature Communications publication, which enables annotation-free training on gigapixel whole-slide images.
The company operates a B2B enterprise model selling software licenses, AI inference subscriptions, and (since December 2025) a fully automated pathology slide scanning solution into hospital pathology laboratories, with hardware partnerships with Hamamatsu Photonics and Techman Robot extending the go-to-market through OEM channels. A second commercial axis targets biopharma, with engagements disclosed with Novartis Taiwan, ACT Genom, and Ono Pharmaceutical for clinical-trial and companion-diagnostics use cases. Regulatory clearances include TFDA, US FDA, CE IVDR, ISO 13485, and ISO 27001, supporting sale in the three largest pathology markets globally. The company crossed NT$100M in annual revenue in 2023, with 60% of revenue from international markets as of late 2025, and completed a two-step public listing on the Taiwan Emerging Stock Board (November 2024) followed by the Taiwan Innovation Board under stock code 7803 (May 2026). Leadership is anchored by CEO Dr. Joe Yeh, a pathologist with NTU and USC training, alongside CTO Chia Kang and COO Steve Yeh.
aetherAI firmographics
Firmographics- Name
- aetherAI
- Legal name
- aetherAI Co., Ltd.
- Website
- https://aetherai.com
- Company type
- Public
- Founded year
- 2015
- Operating status
- Ipo
- Headcount range
- 51–100 employees
- Short description
- aetherAI is a Taipei-based medical-imaging AI company that builds computer-vision software for digital pathology and endoscopy, with deployments in 23+ hospitals across Taiwan, the US, Germany, Japan, and Vietnam, and biopharma engagements with Novartis, ACT Genom, and Ono Pharmaceutical.
- Ownership category
- akta.pro rank
aetherAI industry classification
Industry- Product category
- Digital Pathology AI / Medical Imaging Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where aetherAI is headquartered
LocationHeadquarters
- HQ city
- Taipei
- HQ country
- Taiwan
- HQ region
- Asia
Offices1 record
Markets served
aetherAI business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Software Sales: Sales of pathology AI software to hospitals and medical institutions, including licensing arrangements for diagnostic support systems
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
aetherAI product offering
Product offeringCore offering
aetherAI develops and sells AI-powered digital pathology software for hospitals and medical centers. Its core product, aetherSlide, is a web-based digital pathology image management and viewer platform, complemented by AI diagnostic modules including aetherAI Endo for real-time colonoscopy polyp detection, aetherAI Hema for bone marrow smear cell classification, and an AI-assisted lymph node metastasis assessment workflow. The company's proprietary True GigaPixel AI technology enables annotation-free training on whole-slide images for pathology AI development.
Product overview
aetherAI is Asia's leading medical image AI solution provider offering a digital pathology platform with integrated AI-powered diagnostic support. The core product is aetherSlide, a web-based digital pathology image management and viewer system that provides the foundation for AI applications. Key AI-powered modules include aetherAI Endo (real-time colonoscopy polyp detection), aetherAI Hema (bone marrow smear classification), and the AI-assisted lymph node assessment workflow. The company's True GigaPixel AI technology enables annotation-free training on gigapixel-level whole slide images, overcoming traditional memory constraints in pathology AI development. Solutions serve digital pathology transformation, AI-powered diagnostic support, and biopharma enterprise services.
Differentiator
Problem solved
Functional benefit
Brands
- aetherSlide: Digital pathology image management system and whole slide image viewer platform for clinical reporting and AI research.
- aetherAI Endo
- aetherAI Hema
- True GigaPixel AI
Products and services
- aetherSlide Web-based digital pathology image management and viewer system. Provides whole slide image management, AI model construction environment, image annotation services, and integrated AI-powered diagnostic workflow for pathologists. Designed for hospitals, medical centers, and pathology laboratories undertaking digital pathology transformation.
- aetherAI Endo Real-time AI-powered colorectal polyp detection system for colonoscopy procedures. Detects polyps including non-pedunculated adenomas during endoscopy with 95.8% accuracy and sub-0.2 second latency, processing video at 30 frames per second. Designed for hospitals, gastroenterology departments, and endoscopy centers.
- aetherAI Hema Bone marrow smear AI automatic classification and counting system. Classifies nucleated cells into 15 main categories with 94% average accuracy. Trained on over 1 million curated cells. Designed for hematology laboratories, hospitals, and medical centers.
- aetherAI Hema-BM18
- True GigaPixel AI
- AI-assisted Lymph Node Assessment Workflow AI-assisted workflow for gastric cancer lymph node metastasis detection. Achieves AUC of 0.99 and improves micrometastasis detection sensitivity from 81% to 95%. Designed for pathology departments and cancer centers.
- Fully Automated Pathology Slide Scanning Solution Integrated automated pathology slide scanning solution combining robotics (Techman Robot), digital slide scanning hardware (Hamamatsu Photonics NanoZoomer), and aetherAI's medical imaging AI system for full-process automation from slide handling to scanning and image output.
Companies that use aetherAI
Customer profileNamed customers23 records
Segments1 record
Ideal customer profiles3 records
aetherAI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature1 record
aetherAI partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Hamamatsu Photonics K.K.corePartnership for fully automated pathology slide scanning, enabling integration of aetherAI's pathology AI solutions with Hamamatsu's digital pathology scanning equipment
- Techman Robot (4585)corePartnership for fully automated pathology slide scanning, combining Techman Robot's robotics technology with aetherAI's AI diagnostic capabilities
- Novartis TaiwanminorPharmaceutical partnership with Novartis Taiwan for potential diagnostic-therapeutic integration
- ACT GenomminorPharmaceutical partnership for genomic and diagnostic collaboration
- Ono PharmaceuticalminorCommissioned work partnership with Ono Pharmaceutical for diagnostic development
Scale indicators6 records
Recent moves9 records
Expansion highlights6 records
aetherAI competitors and assessment
Company assessmentDirect peers
- Paige.AI: New York-based digital pathology AI company with FDA-authorized prostate cancer detection products and large-scale hospital deployments. Directly comparable as an AI-first pathology diagnostics vendor targeting hospital pathology departments.
- PathAI: Boston-based AI pathology platform serving biopharma R&D and clinical diagnostics with deep learning models for tissue analysis. Directly comparable as an AI pathology vendor with biopharma and clinical customers and similar whole-slide image technology.
- Owkin: AI-driven pathology and oncology company combining AI diagnostics with federated learning for biopharma research. Comparable as a pathology AI vendor selling into both hospitals and pharma/biotech research workflows.
- Ibex Medical Analytics: Israel-based AI pathology company with multiple CE-marked and deployed cancer detection products across histology workflows. Direct competitor in clinical-grade AI cancer detection on whole-slide images.
- Proscia: Philadelphia-based digital pathology software platform that combines a whole-slide image management system with AI applications. Closely comparable product architecture (viewer + AI workflow) and target market (hospital and research pathology labs).
- Deep Bio: Korean AI pathology company focused on prostate and other cancer detection algorithms. Direct peer in Asia offering deep-learning cancer diagnostics on whole-slide images to clinical pathology departments.
Emerging players
- Lunit: Korean medical imaging AI company best known for mammography AI but expanding into pathology and other oncology imaging. Comparable as an Asia-headquartered AI imaging vendor with hospital enterprise sales motion and FDA/CE clearances.
- Mindpeak: Hamburg-based AI pathology company offering breast and other tissue biomarker quantification tools. Comparable as an EU-based AI pathology vendor with similar biomarker quantification and IHC analysis focus.
- Tribun Health: French digital pathology company (formerly Tribun Health / Keen Eye) offering a whole-slide viewer plus AI modules for pathology workflows. Comparable digital pathology platform with AI integration similar to aetherSlide.
- Indica Labs: US-based digital pathology software company with Halcon image analysis platform widely used in research pathology labs. Comparable as a digital pathology software vendor serving both clinical and research pathology workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
aetherAI social profiles
Digital presenceaetherAI compliance and trust
Trust signalCompliance5 records
aetherAI financial estimates
Financial estimateRevenue estimate
Valuation estimate
aetherAI leadership team
Management profileNumber of profiles
Profiles3 records
aetherAI funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
aetherAI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about aetherAI
What does aetherAI do?
aetherAI develops and sells AI-powered digital pathology software for hospitals and medical centers. Its core product, aetherSlide, is a web-based digital pathology image management and viewer platform, complemented by AI diagnostic modules including aetherAI Endo for real-time colonoscopy polyp detection, aetherAI Hema for bone marrow smear cell classification, and an AI-assisted lymph node metastasis assessment workflow. The company's proprietary True GigaPixel AI technology enables annotation-free training on whole-slide images for pathology AI development.
Is aetherAI a public or private company?
aetherAI is a public company. It is classified as public and is currently ipo.
When was aetherAI founded?
aetherAI was founded in 2015. It employs 51 to 100 people.
Where is aetherAI based?
aetherAI is headquartered in Taipei, Taiwan, in the Asia region.
How does aetherAI make money?
One revenue line is on record: medical Device Software Sales.
Who are aetherAI's main competitors?
Direct peers on record are Paige.AI, PathAI, Owkin, Ibex Medical Analytics, Proscia and Deep Bio. Emerging players are Lunit, Mindpeak, Tribun Health and Indica Labs.
Does aetherAI have an API?
No public API is recorded for aetherAI.
What industry is aetherAI in?
aetherAI's product category is Digital Pathology AI / Medical Imaging Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 334510 and its SIC code is 3845.